| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000045465 |
| Receipt No. | R000049578 |
| Scientific Title | Examination of local recurrence after endoscopic submucosal dissection for superficial colorectal tumors |
| Date of disclosure of the study information | 2021/09/13 |
| Last modified on | 2021/09/13 (Ver. 1) |
| Basic information | ||
| Public title | Examination of local recurrence after endoscopic submucosal dissection for superficial colorectal tumors | |
| Acronym | Risk factors of local recurrence after ESD | |
| Scientific Title | Examination of local recurrence after endoscopic submucosal dissection for superficial colorectal tumors | |
| Scientific Title:Acronym | Risk factors of local recurrence after ESD | |
| Region |
|
|
| Condition | ||
| Condition | More than 20mm superficial colorectal tumors which can be resected using endoscopy. | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aimed to evaluate risk factors after ESD for superficial colorectal tumors. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | En-block R0 resection rate, curative resection rate, complication rate(perforation, postoperative bleeding) |
| Key secondary outcomes | tumor diameter, resected specimen diameter, macroscopic type, location, pathological characteristics, procedure time |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 20mm or more colorectal adenoma, intramucosal or slightly-invaded submucosal colorectal neoplasms were considered eligible. | |||
| Key exclusion criteria | 1.Patients in disagreement with informed consent.
2.Patients unable to follow the course after colorectal ESD |
|||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Showa University Northern Yokohama Hospital | ||||||
| Division name | Digestive Disease Center | ||||||
| Zip code | 224-8503 | ||||||
| Address | 35-1, Chigasaki-chuo, Tsuduki,Yokohama, Kanagawa, Japan | ||||||
| TEL | 045-949-7000 | ||||||
| javier.thierry@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Showa University Northern Yokohama Hospital | ||||||
| Division name | Digestive Disease Center | ||||||
| Zip code | 224-8503 | ||||||
| Address | 35-1, Chigasaki-chuo, Tsuduki,Yokohama, Kanagawa, Japan | ||||||
| TEL | 045-949-7000 | ||||||
| Homepage URL | |||||||
| javier.thierry@gmail.com | |||||||
| Sponsor | |
| Institute | Showa University Northern Yokohama Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Showa University Northern Yokohama Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Showa University Northern Yokohama Hospital |
| Address | 35-1, Chigasaki-chuo, Tsuduki,Yokohama, Kanagawa, Japan |
| Tel | 045-949-7175 |
| irb02syh@ofc.showa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 1344 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This retrospective study included 1344 patients, with a total of 1539 consecutive colorectal lesions, who underwent ESD from September 2003 to December 2019. The main outcome were incidence of local recurrence and its relationship with the clinicopathological factors in long term surveillance. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049578 |